Provided by Tiger Trade Technology Pte. Ltd.

Urogen Pharma Ltd.

24.38
-4.0800-14.34%
Post-market: 24.400.0200+0.08%17:35 EST
Volume:1.39M
Turnover:35.94M
Market Cap:1.14B
PE:-7.04
High:28.69
Open:28.45
Low:24.00
Close:28.46
52wk High:30.00
52wk Low:3.42
Shares:46.81M
Float Shares:37.03M
Volume Ratio:1.57
T/O Rate:3.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4606
EPS(LYR):-2.9590
ROE:-1481.26%
ROA:-33.96%
PB:-9.89
PE(LYR):-8.24

Loading ...

Nov 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jul 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 10, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 20, 2025

Major Issues Report

Form 8-K - Current report